To investigate the effect of iNOS on colitis and colitis-associated carcinogenesis, we treated mice with the iNOS inhibitor AG upon injection of AOM (12 mg/kg), followed by three rounds of DSS treatment (Fig. 7A). This evidence concerns the gene NOS2 and infectious otitis media.